Pharmacokinetic Study of a Novel Cannabidiol (CBD) Formulation in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

September 22, 2025

Primary Completion Date

December 9, 2025

Study Completion Date

January 3, 2026

Conditions
PK in Healthy Volunteers
Interventions
DRUG

CBD soft-gel capsules 600 mg

600 mg

DRUG

CBD soft-gel capsules 900 mg

900 mg

DRUG

Epidyolex

25 mg/kg

Trial Locations (2)

LS11 9EH

RECRUITING

Fortrea Clinical Research Unit (Drapers Yard), Leeds

RECRUITING

Fortrea Clinical Research Unit (Drapers Yard), Leeds

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NW PharmaTech Ltd

INDUSTRY